rs36061201

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006331.8(EMG1):​c.38G>T​(p.Arg13Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,613,054 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0080 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 19 hom. )

Consequence

EMG1
NM_006331.8 missense

Scores

10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.64

Publications

3 publications found
Variant links:
Genes affected
EMG1 (HGNC:16912): (EMG1 N1-specific pseudouridine methyltransferase) This gene encodes an essential, conserved eukaryotic protein that methylates pseudouridine in 18S rRNA. The related protein in yeast is a component of the small subunit processome and is essential for biogenesis of the ribosomal 40S subunit. A mutation in this gene has been associated with Bowen-Conradi syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
PHB2 (HGNC:30306): (prohibitin 2) Enables several functions, including protein C-terminus binding activity; protein N-terminus binding activity; and protein dimerization activity. Involved in several processes, including defense response to virus; positive regulation of cell cycle phase transition; and regulation of transcription, DNA-templated. Located in several cellular components, including cell surface; mitochondrial membrane; and nuclear matrix. Part of mitochondrial prohibitin complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036773384).
BP6
Variant 12-6970961-G-T is Benign according to our data. Variant chr12-6970961-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00797 (1214/152312) while in subpopulation AFR AF = 0.0277 (1152/41560). AF 95% confidence interval is 0.0264. There are 12 homozygotes in GnomAd4. There are 561 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EMG1NM_006331.8 linkc.38G>T p.Arg13Leu missense_variant Exon 1 of 6 ENST00000599672.6 NP_006322.4 Q92979
EMG1NM_001320049.2 linkc.38G>T p.Arg13Leu missense_variant Exon 1 of 5 NP_001306978.1 Q92979
EMG1NR_135131.2 linkn.49G>T non_coding_transcript_exon_variant Exon 1 of 8
PHB2NM_001267700.1 linkc.-418C>A upstream_gene_variant NP_001254629.1 Q99623-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EMG1ENST00000599672.6 linkc.38G>T p.Arg13Leu missense_variant Exon 1 of 6 1 NM_006331.8 ENSP00000470560.1 Q92979
ENSG00000290146ENST00000607161.5 linkn.41G>T non_coding_transcript_exon_variant Exon 1 of 8 2 ENSP00000480420.1 A0A087WWQ2

Frequencies

GnomAD3 genomes
AF:
0.00789
AC:
1201
AN:
152194
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00198
AC:
488
AN:
246618
AF XY:
0.00140
show subpopulations
Gnomad AFR exome
AF:
0.0297
Gnomad AMR exome
AF:
0.000817
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000269
Gnomad OTH exome
AF:
0.000834
GnomAD4 exome
AF:
0.000785
AC:
1146
AN:
1460742
Hom.:
19
Cov.:
32
AF XY:
0.000650
AC XY:
472
AN XY:
726564
show subpopulations
African (AFR)
AF:
0.0280
AC:
938
AN:
33468
American (AMR)
AF:
0.00119
AC:
53
AN:
44580
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86042
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53328
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000387
AC:
43
AN:
1111446
Other (OTH)
AF:
0.00176
AC:
106
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
58
116
173
231
289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00797
AC:
1214
AN:
152312
Hom.:
12
Cov.:
32
AF XY:
0.00753
AC XY:
561
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0277
AC:
1152
AN:
41560
American (AMR)
AF:
0.00294
AC:
45
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68038
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
63
126
189
252
315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00333
Hom.:
21
Bravo
AF:
0.00946
ESP6500AA
AF:
0.0253
AC:
99
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00242
AC:
293
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 10, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
16
DANN
Benign
0.64
DEOGEN2
Benign
0.051
T
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.65
T
MetaRNN
Benign
0.0037
T
PhyloP100
1.6
PrimateAI
Benign
0.48
T
Sift4G
Benign
0.38
T
Polyphen
0.11
B
Vest4
0.38
MVP
0.61
GERP RS
2.3
PromoterAI
-0.048
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.38
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36061201; hg19: chr12-7080124; API